суббота, 3 марта 2012 г.

Word on the Street.

"This particular record has played itself out many times before at FDA."

- Mark Gardner, head of product management for the genetic systems division at Life Technologies Corp., on the FDA's need to develop new regulations for new technologies, such as lab-developed tests

"After a decade, genomics gave us a lot of drug targets. But it stopped there."

- Leerink Swann analyst John …

Комментариев нет:

Отправить комментарий